GREY:ATBPF - Post by User
Post by
TechMooseon Aug 04, 2021 9:57am
414 Views
Post# 33647703
Brookline Capital - BUY Rating for ATE at $9 yesterday
Brookline Capital - BUY Rating for ATE at $9 yesterday Not sure how Brookline Capital assessed the situation that the markets reacted to yesterday. I'm not a subscriber to this research but would appreciate any comments others may have after looking at this report. Given the timing of this report I can’t believe it reflects the bad news we received yesterday. Timing is very dubious. I have emailed Kent Doliver at Brookline to clarify. A $9 BUY rating ...hmmm
Very interested to see how the analyst community will be revising their numbers…especially Canaccord.
Missing your perspectives right now Mugs...I can only guess you are still on vacation... or more likely studying the situation thoughtfully and putting some comments together (and possibly buying additional shares) ;-)
Holding firm on a large position of ATE right now. The info. we have doesn't warrant a 70% sell off but no news will create more panic. Appreciate the constructive comments made by various investors on the liver toxicity issues and potential explanations.
Should be an interesting day for Dan and the team. GLTAL!
TechMoose